FDA approves Moderna COVID vaccine for children, with eligibility limits
TL;DR Summary
The FDA has fully approved Moderna's Covid vaccine, Spikevax, for children aged 6 months to 11 years with certain medical conditions, marking a shift from emergency use authorization, but limits eligibility to children at increased risk of severe illness, raising concerns about vaccination options for healthy infants and young children.
- FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility STAT
- Moderna gets full US approval for COVID shot in at-risk children 6 months and older Reuters
- Why Moderna (MRNA) Stock Is Up Today Yahoo Finance
- Moderna’s Covid Shot Fully Approved by FDA for Use in Children Bloomberg
- FDA gives full approval to Moderna COVID shot for at-risk kids The Hill
Reading Insights
Total Reads
0
Unique Readers
11
Time Saved
3 min
vs 4 min read
Condensed
93%
716 → 50 words
Want the full story? Read the original article
Read on STAT